Protalix Company
Protalix is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Its pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic proteins that target established pharmaceutical markets.
Industry:
Personalized Medicine
Technology:
Biotechnology, Pharmaceutical, Therapeutics
Funding Status:
IPO
Investment Stage:
N/A
Headquarters:
Carmiel, Israel
Employee Number:
200-500
Number Of Exists:
N/A
Investor Type:
N/A
Founded Date:
1993